Scholar Rock Holding Corp (SRRK)
26.89
-0.61
(-2.22%)
USD |
NASDAQ |
Nov 15, 11:49
Scholar Rock Free Cash Flow (Quarterly): -49.22M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -49.22M |
March 31, 2024 | -49.81M |
December 31, 2023 | -37.35M |
September 30, 2023 | -32.27M |
June 30, 2023 | -32.59M |
March 31, 2023 | -43.08M |
December 31, 2022 | -29.02M |
September 30, 2022 | -26.51M |
June 30, 2022 | -35.22M |
March 31, 2022 | -43.01M |
December 31, 2021 | -33.00M |
September 30, 2021 | -37.39M |
June 30, 2021 | -32.80M |
March 31, 2021 | -28.86M |
December 31, 2020 | -21.66M |
Date | Value |
---|---|
September 30, 2020 | -25.23M |
June 30, 2020 | -19.90M |
March 31, 2020 | 2.427M |
December 31, 2019 | -17.54M |
September 30, 2019 | -15.48M |
June 30, 2019 | -17.00M |
March 31, 2019 | -16.21M |
December 31, 2018 | 54.39M |
September 30, 2018 | -9.612M |
June 30, 2018 | -11.64M |
March 31, 2018 | -10.06M |
December 31, 2017 | -6.172M |
September 30, 2017 | -5.783M |
June 30, 2017 | -5.436M |
March 31, 2017 | -4.707M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-49.81M
Minimum
Mar 2024
2.427M
Maximum
Mar 2020
-31.16M
Average
-32.59M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
Cytokinetics Inc | -102.20M |
Regeneron Pharmaceuticals Inc | 1.049B |
Ocugen Inc | -10.42M |
Mirum Pharmaceuticals Inc | -14.58M |
NeuroBo Pharmaceuticals Inc | -5.589M |